News

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides’ Dr. Diwan
SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the ...
Pharmaceutical Technology54m
Paratek expands commercial portfolio with Optinose
Paratek Pharmaceuticals has completed the acquisition of Optinose, valued at almost $330m, broadening its commercial product ...
CNBCTV1844m
Sun Pharma Q4 Results: Profit misses estimate, revenue up 8% YoY; ₹5.50 dividend announced
Sun Pharma posted an 8.1% revenue rise in Q4, but profit fell 19%. EBITDA margins expanded sharply, and the company announced ...